Gene: TTC31
Official Full Name: tetratricopeptide repeat domain 31provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12955 | TTC31 Knockout cell line (HeLa) | Human | TTC31 | 1:3~1:6 | Negative | Online Inquiry |
KO12956 | TTC31 Knockout cell line (HCT 116) | Human | TTC31 | 1:2~1:4 | Negative | Online Inquiry |
KO12957 | TTC31 Knockout cell line (HEK293) | Human | TTC31 | 1:3~1:6 | Negative | Online Inquiry |
KO12958 | TTC31 Knockout cell line (A549) | Human | TTC31 | 1:3~1:4 | Negative | Online Inquiry |
TTC31 Gene Knockout Cell Lines represent a cutting-edge tool in the field of molecular biology, specialized for the functional analysis of gene function and interaction studies. These cell lines have been engineered through advanced CRISPR-Cas9 technology to disrupt the TTC31 gene, which is known for its involvement in cellular processes such as signal transduction and protein degradation pathways. By selectively knocking out this gene, researchers can elucidate its role in various biological processes and disease mechanisms.
The primary function of TTC31 Gene Knockout Cell Lines is to serve as a model for investigating the consequences of TTC31 loss-of-function. This mechanism allows researchers to study alterations in cellular behavior, including changes in proliferation, differentiation, and response to stress signals. Furthermore, these cell lines can be used in drug screening assays to evaluate the efficacy of new therapeutic agents targeted against pathways influenced by TTC31.
The scientific importance of these cell lines cannot be overstated; they enable researchers to gain deep insights into gene function, which is paramount for understanding complex diseases such as cancer, neurodegeneration, and metabolic disorders. Additionally, TTC31 Gene Knockout Cell Lines are valuable in the development of gene-based therapies, as they serve as a foundation for translating basic research into clinical applications.
Compared to conventional methods of gene silencing, such as RNA interference (RNAi), our TTC31 Gene Knockout Cell Lines offer durable and complete gene inactivation, making them a superior choice for long-term studies. This feature ensures the reliability of experimental outcomes, providing researchers with confident results that can influence their hypotheses and drive subsequent investigations.
For researchers and clinicians seeking to innovate and expand their understanding of gene functionality and its implications in health and disease, TTC31 Gene Knockout Cell Lines stand out as essential tools. Our company prides itself on its commitment to advancing biotechnological research through high-quality and robust biological products. With specialized expertise and unwavering quality assurance, we are dedicated to supporting the scientific community in their pursuit of groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.